SunLink Health Systems Inc (A:SSY)
Business Focus: Drug Retailers
| Sector: Consumer Non-Cyclicals | Industry: Drug Retailers |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | SUITE 1120, 900 CIRCLE 75 PARKWAY ATLANTA GA 30339 |
| Tel: | N/A |
| Website: | www.sunlinkhealth.com |
| IR: | See website |
| Key People | ||
| Robert M. Thornton Chairman of the Board, President, Chief Executive Officer | Mark J. Stockslager Chief Financial Officer, Principal Accounting Officer, Director | Byron D. Finn President of SunLink ScriptsRx, LLC | Sheila G. Brockman Vice President, Chairperson of Southern Health Corporation of Houston, Inc |
| Business Overview |
| SunLink Health Systems, Inc., through subsidiaries, owns businesses which provide healthcare products and services in certain markets in the southeastern United States. The Company operates through two segments: Healthcare Services and Pharmacy. The Healthcare Services segment subsidiaries owns and operates Trace Regional Medical Center (Trace), a 49-bed community hospital, clinics and a 66-bed nursing home in Mississippi, and an information technology (IT) service company based in Georgia. The Pharmacy segment subsidiary owns and operates a pharmacy business in Louisiana with four operational areas. The operational areas include retail pharmacy products and services provided to residents of southwestern Louisiana; institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products; non-institutional pharmacy services; and durable medical equipment (DME) consisting primarily of the sale and rental of products. |
| Financial Overview |
| For the six months ended 31 December 2023, SunLink Health Systems Inc revenues decreased 21% to $17.1M. Net loss before extraordinary items totaled $835K vs. income of $733K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects Gain on sale of assets decrease of 85% to $2K (income). |
| Employees: | 1,376 as of Jun 30, 2011 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $2.52M as of Dec 31, 2023 |
| Annual revenue (TTM): | $39.59M as of Dec 31, 2023 |
| EBITDA (TTM): | -$2.00M as of Dec 31, 2023 |
| Net annual income (TTM): | -$3.00M as of Dec 31, 2023 |
| Free cash flow (TTM): | -$3.09M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 7,040,603 as of Feb 12, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.